Page last updated: 2024-09-05

varenicline and Anxiety Neuroses

varenicline has been researched along with Anxiety Neuroses in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Anthenelli, RM; Ayers, CR; Evins, AE; Heffner, JL; Lawrence, D; McRae, T; Russ, C1
Anthenelli, RM; Benowitz, NL; Evins, AE; Krishen, A; Lawrence, D; Maravic, MC; McRae, T; Russ, C; St Aubin, L; West, R1
Baker, TB; Cook, JW; Piper, ME; Schlam, TR; Smith, SS1
Ditre, JW; Farris, SG; Leventhal, AM; Schmidt, NB; Zvolensky, MJ1
Miller, ME; Tidey, JW1
Muheim, L1

Reviews

1 review(s) available for varenicline and Anxiety Neuroses

ArticleYear
Smoking cessation and reduction in people with chronic mental illness.
    BMJ (Clinical research ed.), 2015, Sep-21, Volume: 351

    Topics: Anxiety Disorders; Bipolar Disorder; Bupropion; Electronic Nicotine Delivery Systems; Humans; Mental Disorders; Mentally Ill Persons; Nicotinic Agonists; Prevalence; Reinforcement, Psychology; Schizophrenia; Smoking; Smoking Cessation; Stress Disorders, Post-Traumatic; Tobacco Use Cessation Devices; United Kingdom; United States; Varenicline

2015

Trials

4 trial(s) available for varenicline and Anxiety Neuroses

ArticleYear
Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active- and placebo-controlled EAGLES trial.
    Depression and anxiety, 2020, Volume: 37, Issue:3

    Topics: Adult; Anxiety Disorders; Humans; Nicotinic Agonists; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2020
Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES.
    Addiction (Abingdon, England), 2018, Volume: 113, Issue:8

    Topics: Adult; Age Factors; Anxiety Disorders; Bupropion; Double-Blind Method; Ethnicity; Female; Humans; International Cooperation; Male; Middle Aged; Mood Disorders; Prognosis; Psychotic Disorders; Psychotropic Drugs; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Treatment Outcome; United States; Varenicline

2018
Anxiety Sensitivity and Distress Tolerance in Smokers: Relations With Tobacco Dependence, Withdrawal, and Quitting Success†.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2020, 01-27, Volume: 22, Issue:1

    Topics: Adolescent; Adult; Anxiety Disorders; Child; Ecological Momentary Assessment; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Smokers; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder; Varenicline; Young Adult

2020
    Praxis, 2016, Volume: 105, Issue:24

    Topics: Adolescent; Adult; Aged; Anxiety Disorders; Bupropion; Cohort Studies; Comorbidity; Double-Blind Method; Female; Humans; Male; Middle Aged; Mood Disorders; Nicotine; Smoking Cessation; Varenicline; Young Adult

2016

Other Studies

1 other study(ies) available for varenicline and Anxiety Neuroses

ArticleYear
Emotional disorders and smoking: relations to quit attempts and cessation strategies among treatment-seeking smokers.
    Addictive behaviors, 2015, Volume: 40

    Topics: Adult; Anxiety Disorders; Benzazepines; Bupropion; Cross-Sectional Studies; Depressive Disorder; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline; Young Adult

2015